Literature DB >> 5118689

Methyl-GAG (NSC-32946) in the treatment of esophagus cancer.

G Falkson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5118689

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

Review 1.  Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1986-08       Impact factor: 1.798

2.  Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.

Authors:  R B Vance; W A Knight; T T Chen; J J Costanzi; A F LoBuglio
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

3.  13-Cis-retinoic acid and interferon alpha-2a in patients with advanced esophageal cancer: a phase II trial.

Authors:  C F Slabber; G Falkson; W Burger; L Schoeman
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

4.  Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

Authors:  Joanne F Rossman; Carla I Falkson; Ronghui Xu; Coenraad F Slabber; Bernard A Mason; Mary F Mulcahy; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2011-01

5.  Trimetrexate in advanced carcinoma of the esophagus.

Authors:  A S Alberts; G Falkson; M Badata; A P Terblanche; E U Schmid
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.